Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Stanski

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
Anesthesiology|March 1, 1992
Improving the clinical utility of anesthetic drug pharmacokineticsS L Shafer, D R Stanski
Anesthesiology|June 1, 1985
The effect of increasing age on thiopental disposition and anesthetic requirementT D Homer, D R Stanski
Clinical Pharmacology and Therapeutics|May 9, 2008
Pharmacokinetics and pharmacodynamics of intravenously administered anesthetic drugs: concepts and lessons for drug developmentS E Kern, D R Stanski
Clinical Pharmacology and Therapeutics|December 1, 1996
Population pharmacodynamic model for ketorolac analgesiaJ W Mandema, D R Stanski
Anesthesiology|February 1, 1983
The role of metabolism and protein binding in thiopental anesthesiaP G Burch, D R Stanski
Clinical Pharmacology and Therapeutics|August 1, 1982
Decreased protein binding and thiopental kineticsP G Burch, D R Stanski
Journal of Pharmaceutical Sciences|January 1, 1985
Factors affecting the measurement of lidocaine protein binding by equilibrium dialysis in human serumK V Ponganis, D R Stanski
Anesthesiology|March 1, 1990
Population pharmacokinetics and pharmacodynamics of thiopental: the effect of age revisitedD R Stanski, P O Maitre
Handbook of Experimental Pharmacology|January 5, 2008
Defining depth of anesthesiaS L Shafer, D R Stanski
Revista Espanola De Anestesiologia Y Reanimacion|July 26, 2005
Lessons learned in drug development from anesthesiaP L Gambús, D R Stanski
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
Anesthesiology|March 1, 1992
Improving the clinical utility of anesthetic drug pharmacokineticsS L Shafer, D R Stanski
Anesthesiology|June 1, 1985
The effect of increasing age on thiopental disposition and anesthetic requirementT D Homer, D R Stanski
Clinical Pharmacology and Therapeutics|May 9, 2008
Pharmacokinetics and pharmacodynamics of intravenously administered anesthetic drugs: concepts and lessons for drug developmentS E Kern, D R Stanski
Clinical Pharmacology and Therapeutics|December 1, 1996
Population pharmacodynamic model for ketorolac analgesiaJ W Mandema, D R Stanski
Anesthesiology|February 1, 1983
The role of metabolism and protein binding in thiopental anesthesiaP G Burch, D R Stanski
Clinical Pharmacology and Therapeutics|August 1, 1982
Decreased protein binding and thiopental kineticsP G Burch, D R Stanski
Journal of Pharmaceutical Sciences|January 1, 1985
Factors affecting the measurement of lidocaine protein binding by equilibrium dialysis in human serumK V Ponganis, D R Stanski
Anesthesiology|March 1, 1990
Population pharmacokinetics and pharmacodynamics of thiopental: the effect of age revisitedD R Stanski, P O Maitre
Handbook of Experimental Pharmacology|January 5, 2008
Defining depth of anesthesiaS L Shafer, D R Stanski
Revista Espanola De Anestesiologia Y Reanimacion|July 26, 2005
Lessons learned in drug development from anesthesiaP L Gambús, D R Stanski
Pageof 11